remained

Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%

Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for…

2 weeks ago

Asia Pacifics Demand for IT and Business Services Slows in Q2, ISG Index Shows

Despite 16% growth in cloud ACV, the combined market was down slightly on slumping managed services demandSYDNEY--(BUSINESS WIRE)--$III #AI--Asia Pacific’s…

4 months ago